Autologous Stem Cell Treatment for Chronic Lung Disease Study

CompletedOBSERVATIONAL
Enrollment

207

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

June 1, 2017

Study Completion Date

June 9, 2017

Conditions
COPDInterstitial Lung Disease
Interventions
PROCEDURE

Cell therapy

Each participant will receive cell therapy with stem cells harvested either from peripheral blood or from bone marrow plus peripheral blood; after harvest, cells are processed and returned to the patient via peripheral circulation on the same day.

Trial Locations (1)

75231

Lung Institute Dallas, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lung Institute

INDUSTRY

NCT03044431 - Autologous Stem Cell Treatment for Chronic Lung Disease Study | Biotech Hunter | Biotech Hunter